President Trump is threatening to withhold funds from supervised drug consumption sites and potentially pursue criminal ...

President Trump wants to end homelessness in America. His plan? Make it easier to involuntarily treat people with serious ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

European regulators said that a Duchenne gene therapy should not be approved, imperiling the treatment that is also facing ...

HCA Healthcare and Tenet Healthcare, for-profit chains that collectively own 240 hospitals, both said their revenue and ...

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...

Preauthorization is about to enter the lives of many seniors who have chosen traditional Medicare over MA, write former CMS ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that ...

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the ...